Ligand Pharmaceuticals | LGND - Batas Pemasukan





Batas Pemasukan Perubahan Tanggal
Agenus USD -10.63M 74.49M 2025-12
Amgen USD 1.82B 486M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
Baxter International USD -15M 1.11B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Enviri Corporation USD -84.28M 61.97M 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Merck USD -4.24B 7.2B 2026-03
Pacira USD 2.92M 1.28M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 28.71M 12.44M 2026-03